Compare Excel Industries with Similar Stocks
Dashboard
Poor long term growth as Net Sales has grown by an annual rate of 9.54% and Operating profit at 1.26% over the last 5 years
Flat results in Sep 25
Despite the size of the company, domestic mutual funds hold only 0.01% of the company
Below par performance in long term as well as near term
Stock DNA
Specialty Chemicals
INR 1,156 Cr (Small Cap)
16.00
29
1.50%
-0.11
4.07%
0.64
Total Returns (Price + Dividend) 
Latest dividend: 13.75 per share ex-dividend date: Aug-14-2025
Risk Adjusted Returns v/s 
Returns Beta
News
When is the next results date for Excel Industries Ltd?
The next results date for Excel Industries Ltd is scheduled for 03 February 2026....
Read full news article
Excel Industries Ltd is Rated Sell
Excel Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 13 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Excel Industries Ltd Opens Strong with Significant Gap Up on 22 Jan 2026
Excel Industries Ltd witnessed a robust start to the trading session on 22 Jan 2026, opening with a significant gap up of 8.59%, reflecting positive market sentiment and strong overnight catalysts. The stock outperformed its sector and broader market indices, sustaining momentum through the day despite notable volatility.
Read full news article Announcements 
Application Seeking Reclassification Of Status From Promoter Group Category To Public Category
28-Jan-2026 | Source : BSEReclassification application by a Promoter under regulation 31A of SEBI (LODR) regulations 2015.
Board Meeting Intimation for Notice Of Board - Regulation 29(1) Of SEBI ( Listing Obligations And Disclosure Requirements) Regulations 2015
22-Jan-2026 | Source : BSEExcel Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Notice is hereby given that a Meeting of Board of Directors of the Company will be held on Tuesday 3rd February 2026 inter - alia to consider and approve Unaudited Financial Results of the Company for the quarter ended 31st December 2025. In continuation of our letter dated 29th December 2025 for closure of trading window for the aforesaid purpose the Trading window for trading in the Companys securities will continue to remain close till 5th February 2026 pursuant to the Companys Code of Conduct for prevention of Insider Trading. The Trading Window shall re-open on 6th February 2026. Accordingly all concerned to whom the above said code is applicable are advised not to trade in the Companys securities during the period of closure of the Trading Window. The Trading Window will however be open for general investors.
Closure of Trading Window
22-Jan-2026 | Source : BSEPursuant to the Provisions of Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a Meeting of Board of Directors of the Company will be held on Tuesday 3rd February 2026 inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter ended 31st December 2025. In continuation of our letter dated 29th December 2025 for closure of trading window for the aforesaid purpose the Trading Window for trading in Companys securities will continue to remain closed till 5th February 2026 pursuant to the Companys Code of Conduct for Prevention of Insider Trading. The Trading Window shall re-open on 6th February 2026. Accordingly all concerned to whom the above said code is applicable are advised not to trade in the Companys securities during the period of closure of the Trading Window. The Trading window will however be open for general investors.
Corporate Actions 
03 Feb 2026
Excel Industries Ltd has declared 275% dividend, ex-date: 14 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 4 Schemes (0.01%)
Held by 44 FIIs (2.01%)
Anshul Specialty Molecules Private Limited (42.92%)
Life Insurance Corporation Of India (6.69%)
30.92%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -12.69% vs 24.89% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -37.23% vs 172.04% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 8.60% vs 29.46% in Sep 2024
Growth in half year ended Sep 2025 is -17.62% vs 770.76% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 23.22% vs -31.39% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 605.03% vs -86.70% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 18.39% vs -24.19% in Mar 2024
YoY Growth in year ended Mar 2025 is 401.53% vs -78.72% in Mar 2024






